Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Published:2017-03 Issue:3 Volume:18 Page:336-346
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Erlandsson Johan,Holm Torbjörn,Pettersson David,Berglund Åke,Cedermark Björn,Radu Calin,Johansson Hemming,Machado Mikael,Hjern Fredrik,Hallböök Olof,Syk Ingvar,Glimelius Bengt,Martling Anna

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects;Frykholm;Dis Colon Rectum,1993

2. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group;Cedermark;Cancer,1995

3. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study;Martling;Cancer,2001

4. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001

5. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial;Sebag-Montefiore;Lancet,2009

Cited by 486 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study;Radiotherapy and Oncology;2024-11

2. Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial;Annals of Oncology;2024-10

3. The risk for rectal cancer recurrence and overall mortality is not increased in men previously diagnosed with prostate cancer: a report from the Swedish colorectal cancer registry;International Journal of Colorectal Disease;2024-09-03

4. A Review of Neoadjuvant Therapy and the Watch-and-Wait Protocol in Rectal Cancer: Current Evidence and Future Directions;Cureus;2024-09-02

5. Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review;Cancer Treatment Reviews;2024-09